Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2016, Article ID 5093537, 9 pages
http://dx.doi.org/10.1155/2016/5093537
Research Article

Comparative Pharmacokinetics and Bioavailability of Epimedin C in Rat after Intramuscular Administration of Epimedin C, a Combination of Four Flavonoid Glycosides and Purified Herba Epimedii Extract

1ImVin Pharmaceutical Co., Ltd., 2 Fangcaodian Road, Guangzhou 510663, China
2Guangdong Provincial Hospital of Chinese Medicine, 111 Dade Road, Guangzhou 510120, China

Received 23 February 2016; Revised 13 June 2016; Accepted 13 June 2016

Academic Editor: Mohamed Abdel-Rehim

Copyright © 2016 Shunjun Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. B. Hu, L. J. Chen, H. B. Lu, and L. L. Liu, “Systematic evaluation on Chuan-Ke-Zhi for treating chronic obstructive pulmonary disease,” China Pharmaceuticals, vol. 22, no. 23, pp. 9–12, 2013. View at Google Scholar
  2. M. L. Hong, X. H. Huang, H. N. Chen et al., “Effect of Chuankezhi injection on life quality in patients with stable chronic obstructive pulmonary disease,” Journal of Emergency in Traditional Chinese Medicine, vol. 21, no. 8, pp. 1214–1216, 2012. View at Google Scholar
  3. H. M. An, H. Ding, B. Hu, S. S. Liu, M. J. Yang, and S. Q. Du, “Clinical research on treatment of acute attack of bronchial asthma in children with Chuan-Ke-Zhi injection,” Traditional Chinese Drug Research & Clinical Pharmacology, vol. 13, no. 2, pp. 71–74, 2002. View at Google Scholar
  4. H. Y. Zhang, “Clinical observation of Chuan-Ke-Zhi in treating remittent asthma of spleen-kidney yang deficiency,” Shanghai Journal of Traditional Chinese Medicine, vol. 36, no. 4, pp. 13–14, 2002. View at Google Scholar
  5. M. Xia, Y. B. Cai, X. Fei, and L. F. Cao, “Mechanisms of Chuan-Ke-Zhi in suppressing inflammatory reaction in asthmatic rats,” Shanghai Journal of Traditional Chinese Medicine, vol. 47, no. 1, pp. 70–73, 2013. View at Google Scholar
  6. H. Y. Zhang, W. Ni, J. F. Zhang, Y. L. Zhang, and L. X. Wang, “Experimental study of nebulizing Chuan-Ke-Zhi in modulating the immuno-imbalance of asthmatic rats,” Shanghai Journal of Traditional Chinese Medicine, vol. 37, no. 12, pp. 904–906, 2003. View at Google Scholar
  7. Y.-P. Wang, L.-G. Chen, and X.-L. Wu, “Effect of CKZ on GVHD in mouse allogeneic bone marrow transplantation,” Chinese Pharmacological Bulletin, vol. 28, no. 4, pp. 589–590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. H. Sun, Y. X. Zhang, B. Song, and Y. Y. Zeng, “Effect of Chuan-Ke-Zhi on murine peritoneal macrophages in vitro,” Journal of Jinan University (Natural Science & Medical Edition), vol. 33, no. 4, pp. 589–590, 2012. View at Google Scholar
  9. J. X. Zhao, Y. Y. Zeng, Q. Wang, Y. Yu, and T. Wang, “Effects of CKZ on Th1/Th2 cytokine repertoire of human peripheral blood mononuclear cells,” Chinese Journal of Immunology, vol. 22, no. 4, pp. 356–359, 2006. View at Google Scholar
  10. L. Tao, Clinical study of Chuan-Ke-Zhi on medium or late stage primary liver cancer (PLC) [M.S. thesis], Guangzhou University of Chinese Medicine, 2005.
  11. Q. H. She, R. S. Chen, K. J. Tan, Y. Cao, and W. Z. Wang, “Clinical observation of Chuan-Ke-Zhi in treating 40 cases with medium or late stage lung cancer,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 20, no. 7, pp. 442–443, 2005. View at Google Scholar
  12. Q. Zhang and J. Cheng, “Clinical observations of Chuankezhi injection treatment on 20 cases of advanced lung cancer with COPD,” Chinese General Practice, vol. 13, no. 21, pp. 2397–2399, 2010. View at Google Scholar
  13. J. Wang, “Cure for acquired immunodeficiency syndrome—a global battle,” Chinese Journal of Integrative Medicine, vol. 20, no. 2, pp. 83–87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. L.-K. Pei, B.-L. Guo, and W.-H. Huang, “Studies on fingerprinting and identification of main species of Herba Epimedii,” China Journal of Chinese Materia Medica, vol. 33, no. 14, pp. 1662–1668, 2008. View at Google Scholar · View at Scopus
  15. N. Meng, K. Kong, and S. W. Li, “Advances in studies on chemical constituents and pharmaceutical activities in species of Epimedium,” Acta Botanica Boreali-Occidentalia Sinica, vol. 30, no. 5, pp. 1063–1073, 2010. View at Google Scholar
  16. L. C. Ye and J. M. Chen, “Advances in study on pharmacological effects of Epimedium,” China Journal of Chinese Materia Medica, vol. 26, no. 5, pp. 293–295, 2001. View at Google Scholar · View at Scopus
  17. C. J. Liu and C. Li, “A review on pharmacological effects of Epimedium,” Subtropical Plant Science, vol. 43, no. 2, pp. 183–186, 2014. View at Google Scholar
  18. S. Koga, Y. Shoyama, and I. Nishioka, “Studies on Epimedium species: flavonol glycosides and isozymes,” Biochemical Systematics and Ecology, vol. 19, no. 4, pp. 315–318, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Z. Wang and X. D. Geng, “Isolation and preparation of five flavonol glycosides from Epimedium sagittatum by reversed phase liquid chromatography,” Fenxi Huaxue, vol. 33, no. 1, pp. 106–108, 2005. View at Google Scholar · View at Scopus
  20. T.-Z. Liu, C.-Y. Chen, S.-J. Yiin et al., “Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21Cip1 and p27 Kip1,” Food and Chemical Toxicology, vol. 44, no. 2, pp. 227–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. L. Zhu, S. J. Xu, Y. Feng, S. Sun, Y. J. Xu, and L. Yang, “Simultaneous quantification of four flavonoid glycosides in Chuankezhi injection using LC-MS/MS,” Traditional Chinese Drug Research and Clinical Pharmacology, vol. 26, no. 3, pp. 244–248, 2015. View at Google Scholar
  22. C.-J. Lee, Y.-T. Wu, T. Y. Hsueh, L.-C. Lin, and T.-H. Tsai, “Pharmacokinetics and oral bioavailability of epimedin C after oral administration of epimedin C and Herba Epimedii extract in rats,” Biomedical Chromatography, vol. 28, no. 5, pp. 630–636, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Li, Z. Xiong, and F. Li, “Determination of epimedin C in rat plasma by reversed-phase high-performance chromatography after oral administration of Herba Epimedii extract,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 821, no. 2, pp. 235–239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Lam, S. Bussom, F. Guan et al., “Chemotherapy: the four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity,” Science Translational Medicine, vol. 2, no. 45, pp. 45–ra59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Hou, Y. Nie, B. Cheng et al., “Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa–induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways,” Acta Pharmaceutica Sinica B, vol. 6, no. 3, pp. 212–221, 2016. View at Publisher · View at Google Scholar
  26. Y. Zhang, Y. Lin, H. Zhao, Q. Guo, C. Yan, and N. Lin, “Revealing the effects of the herbal pair of euphorbia kansui and glycyrrhiza on hepatocellular carcinoma ascites with integrating network target analysis and experimental validation,” International Journal of Biological Sciences, vol. 12, no. 5, pp. 594–606, 2016. View at Publisher · View at Google Scholar
  27. Y. Fan, S. Man, H. Li, Y. Liu, Z. Liu, and W. Gao, “Analysis of bioactive components and pharmacokinetic study of herb-herb interactions in the traditional Chinese patent medicine Tongmai Yangxin Pill,” Journal of Pharmaceutical and Biomedical Analysis, vol. 120, pp. 364–373, 2016. View at Publisher · View at Google Scholar · View at Scopus